NYSEARCA:ALT - iShares Diversified Alternatives Trust Stock Price, Price Target & More

$0.71 -0.04 (-5.33 %)
(As of 04/20/2018 04:00 PM ET)
Previous Close$0.76
Today's Range$0.68 - $0.74
52-Week Range$0.68 - $8.00
Volume429,550 shs
Average Volume304,443 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About iShares Diversified Alternatives Trust (NYSEARCA:ALT)

iShares Diversified Alternatives Trust (the Trust) is a commodity pool. The investment objective of the Trust is to maximize absolute returns from its investments in certain futures and/or forward contracts. The Trust holds long and/or short positions in foreign currency forward contracts and exchange-traded futures contracts involving assets, such as commodities, currencies, interest rates or certain eligible stock and/or bond indices. iShares Delaware Trust Sponsor LLC is the Sponsor of the Trust. BlackRock Institutional Trust Company, N.A. is the Trustee of the Trust. Investments for the Trust's portfolio are selected by BlackRock Fund Advisors (the Advisor).

Receive ALT News and Ratings via Email

Sign-up to receive the latest news and ratings for ALT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNYSEARCA:ALT
CUSIPN/A
Phone+1-415-6702000

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares22,270,000

How to Become a New Pot Stock Millionaire

iShares Diversified Alternatives Trust (NYSEARCA:ALT) Frequently Asked Questions

What is iShares Diversified Alternatives Trust's stock symbol?

iShares Diversified Alternatives Trust trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "ALT."

What price target have analysts set for ALT?

1 brokers have issued 12-month price objectives for iShares Diversified Alternatives Trust's shares. Their predictions range from $6.00 to $6.00. On average, they anticipate iShares Diversified Alternatives Trust's stock price to reach $6.00 in the next twelve months. View Analyst Ratings for iShares Diversified Alternatives Trust.

Who are some of iShares Diversified Alternatives Trust's key competitors?

Has iShares Diversified Alternatives Trust been receiving favorable news coverage?

News coverage about ALT stock has trended somewhat positive this week, Accern Sentiment reports. Accern ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. iShares Diversified Alternatives Trust earned a news sentiment score of 0.11 on Accern's scale. They also gave media coverage about the company an impact score of 45.50 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

How do I buy shares of iShares Diversified Alternatives Trust?

Shares of ALT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is iShares Diversified Alternatives Trust's stock price today?

One share of ALT stock can currently be purchased for approximately $0.71.

How can I contact iShares Diversified Alternatives Trust?

iShares Diversified Alternatives Trust's mailing address is c/o BlackRock Asset Mgmt Internatnl Inc. 400 Howard Street, SAN FRANCISCO, CA 94105, United States. The company can be reached via phone at +1-415-6702000.


MarketBeat Community Rating for iShares Diversified Alternatives Trust (ALT)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  38 (Vote Outperform)
Underperform Votes:  38 (Vote Underperform)
Total Votes:  76
MarketBeat's community ratings are surveys of what our community members think about iShares Diversified Alternatives Trust and other stocks. Vote "Outperform" if you believe ALT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALT will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

iShares Diversified Alternatives Trust (NYSEARCA:ALT) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for iShares Diversified Alternatives Trust in the last 12 months. Their average twelve-month price target is $6.00, suggesting that the stock has a possible upside of 745.07%. The high price target for ALT is $6.00 and the low price target for ALT is $6.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $6.00$6.00$6.00$6.00
Price Target Upside: 745.07% upside164.32% upside164.32% upside164.32% upside

iShares Diversified Alternatives Trust (NYSEARCA:ALT) Consensus Price Target History

Price Target History for iShares Diversified Alternatives Trust (NYSEARCA:ALT)

iShares Diversified Alternatives Trust (NYSEARCA:ALT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
10/9/2017Piper JaffrayInitiated CoverageOverweight -> Overweight$6.00View Rating Details
(Data available from 4/20/2016 forward)

Earnings

Dividends

iShares Diversified Alternatives Trust (NYSEARCA:ALT) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

iShares Diversified Alternatives Trust (NYSEARCA ALT) Insider Trading and Institutional Ownership History

Insider Trading History for iShares Diversified Alternatives Trust (NYSEARCA:ALT)

iShares Diversified Alternatives Trust (NYSEARCA ALT) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/29/2017Derace L SchafferDirectorBuy97,410$1.92$187,027.20View SEC Filing  
12/28/2017Derace L SchafferDirectorBuy58,711$1.92$112,725.12550,754View SEC Filing  
12/27/2017Derace L SchafferDirectorBuy147,130$1.76$258,948.80362,895View SEC Filing  
12/22/2017Derace L SchafferDirectorBuy17,982$1.61$28,951.02362,895View SEC Filing  
12/7/2017Derace L SchafferDirectorBuy23,745$1.78$42,266.10337,274View SEC Filing  
12/5/2017Derace L SchafferDirectorBuy26,010$1.79$46,557.90300,373View SEC Filing  
11/30/2017Derace L SchafferDirectorBuy33,315$1.91$63,631.65274,238View SEC Filing  
11/27/2017Derace L SchafferDirectorBuy21,808$2.03$44,270.24245,296View SEC Filing  
11/24/2017Derace L SchafferDirectorBuy6,505$2.02$13,140.10245,296View SEC Filing  
11/22/2017Derace L SchafferDirectorBuy5,261$2.10$11,048.10245,296View SEC Filing  
11/20/2017Derace L SchafferDirectorBuy4,800$2.07$9,936.00227,999View SEC Filing  
11/17/2017Derace L SchafferDirectorBuy6,295$2.12$13,345.40227,999View SEC Filing  
8/25/2017Derace L SchafferDirectorBuy67,326$2.25$151,483.50171,704View SEC Filing  
8/23/2017Derace L SchafferDirectorBuy50,000$2.21$110,500.00105,068View SEC Filing  
6/2/2017John GillDirectorBuy1,000$4.34$4,340.0083,224View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

iShares Diversified Alternatives Trust (NYSEARCA ALT) News Headlines

Source:
DateHeadline
iShares Diversified Alternatives Trust (ALT) Research Coverage Started at Piper JaffrayiShares Diversified Alternatives Trust (ALT) Research Coverage Started at Piper Jaffray
www.americanbankingnews.com - April 7 at 8:50 PM
Altimmune Announces Financial Results for the Year Ended December 31, 2017 and Provides Corporate UpdateAltimmune Announces Financial Results for the Year Ended December 31, 2017 and Provides Corporate Update
finance.yahoo.com - March 29 at 10:42 AM
Here’s What’s Moving Esperion And Altimmune, Inc.Here’s What’s Moving Esperion And Altimmune, Inc.
finance.yahoo.com - March 28 at 3:50 PM
Altimmune Announces Positive Data From Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine and Provides an Update on Its Phase 1b Study of HepTcell Targeted Immunotherapy in Chronic Hepatitis B InfectionAltimmune Announces Positive Data From Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine and Provides an Update on Its Phase 1b Study of HepTcell Targeted Immunotherapy in Chronic Hepatitis B Infection
finance.yahoo.com - March 27 at 10:43 AM
Altimmune to Participate at the H.C. Wainwright Global Life Sciences ConferenceAltimmune to Participate at the H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 23 at 10:05 AM
Altimmune to Announce Year End 2017 Financial Results on March 29Altimmune to Announce Year End 2017 Financial Results on March 29
finance.yahoo.com - March 21 at 11:30 AM
Altimmune Announces Pre-Clinical Data From its SparVax-L Anthrax Vaccine ProgramAltimmune Announces Pre-Clinical Data From its SparVax-L Anthrax Vaccine Program
finance.yahoo.com - March 12 at 4:39 PM
Altimmune to Participate at Two Investor Conferences in MarchAltimmune to Participate at Two Investor Conferences in March
finance.yahoo.com - March 6 at 10:18 AM
Altimmune Announces Notice of Allowance on Patent Covering Use of NasoShield in the U.S.Altimmune Announces Notice of Allowance on Patent Covering Use of NasoShield in the U.S.
finance.yahoo.com - January 23 at 9:00 AM
Altimmune to Participate at the Noble Capital 14th Annual Investor ConferenceAltimmune to Participate at the Noble Capital 14th Annual Investor Conference
finance.yahoo.com - January 22 at 4:58 PM
iShares Diversified Alternatives Trust (ALT) Director Derace L. Schaffer Purchases 97,410 SharesiShares Diversified Alternatives Trust (ALT) Director Derace L. Schaffer Purchases 97,410 Shares
www.americanbankingnews.com - January 2 at 7:34 PM
iShares Diversified Alternatives Trust (ALT) Director Derace L. Schaffer Acquires 58,711 SharesiShares Diversified Alternatives Trust (ALT) Director Derace L. Schaffer Acquires 58,711 Shares
www.americanbankingnews.com - January 2 at 7:32 PM
5 Emerging Market Equity ETFs to Watch in 20185 Emerging Market Equity ETFs to Watch in 2018
www.msn.com - December 29 at 8:05 AM
Derace L. Schaffer Buys 17,982 Shares of iShares Diversified Alternatives Trust (ALT) StockDerace L. Schaffer Buys 17,982 Shares of iShares Diversified Alternatives Trust (ALT) Stock
www.americanbankingnews.com - December 28 at 5:10 PM
Insider Buying: iShares Diversified Alternatives Trust (ALT) Director Purchases 147,130 Shares of StockInsider Buying: iShares Diversified Alternatives Trust (ALT) Director Purchases 147,130 Shares of Stock
www.americanbankingnews.com - December 28 at 4:08 PM
Altimmune Announces Positive Initial Data from Its HepTcell Phase 1 StudyAltimmune Announces Positive Initial Data from Its HepTcell Phase 1 Study
finance.yahoo.com - December 21 at 8:04 AM
Altimmune, Inc. (ALT) Director Derace L. Schaffer Purchases 23,745 SharesAltimmune, Inc. (ALT) Director Derace L. Schaffer Purchases 23,745 Shares
www.americanbankingnews.com - December 8 at 8:52 PM
Altimmune, Inc. (ALT) Director Purchases $46,557.90 in StockAltimmune, Inc. (ALT) Director Purchases $46,557.90 in Stock
www.americanbankingnews.com - December 5 at 9:52 PM
Insider Buying: Altimmune, Inc. (ALT) Director Acquires 33,315 Shares of StockInsider Buying: Altimmune, Inc. (ALT) Director Acquires 33,315 Shares of Stock
www.americanbankingnews.com - November 30 at 8:46 PM
Derace L. Schaffer Acquires 5,261 Shares of Altimmune, Inc. (ALT) StockDerace L. Schaffer Acquires 5,261 Shares of Altimmune, Inc. (ALT) Stock
www.americanbankingnews.com - November 27 at 8:40 PM
Altimmune, Inc. (ALT) Director Derace L. Schaffer Acquires 21,808 SharesAltimmune, Inc. (ALT) Director Derace L. Schaffer Acquires 21,808 Shares
www.americanbankingnews.com - November 27 at 8:40 PM
Insider Buying: Altimmune, Inc. (ALT) Director Acquires 6,505 Shares of StockInsider Buying: Altimmune, Inc. (ALT) Director Acquires 6,505 Shares of Stock
www.americanbankingnews.com - November 27 at 8:40 PM
Insider Buying: Altimmune, Inc. (ALT) Director Buys 6,295 Shares of StockInsider Buying: Altimmune, Inc. (ALT) Director Buys 6,295 Shares of Stock
www.americanbankingnews.com - November 21 at 9:56 PM
Derace L. Schaffer Buys 67,326 Shares of iShares Diversified Alternatives Trust (ALT) StockDerace L. Schaffer Buys 67,326 Shares of iShares Diversified Alternatives Trust (ALT) Stock
www.americanbankingnews.com - August 28 at 7:40 PM
Insider Buying: iShares Diversified Alternatives Trust (ALT) Director Buys 50,000 Shares of StockInsider Buying: iShares Diversified Alternatives Trust (ALT) Director Buys 50,000 Shares of Stock
www.americanbankingnews.com - August 23 at 8:04 PM

SEC Filings

iShares Diversified Alternatives Trust (NYSEARCA:ALT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

iShares Diversified Alternatives Trust (NYSEARCA:ALT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

iShares Diversified Alternatives Trust (NYSEARCA ALT) Stock Chart for Friday, April, 20, 2018

Loading chart…

This page was last updated on 4/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.